Aroa Biosurgery (ASX:ARX) COGS-to-Revenue : 0.13 (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery COGS-to-Revenue?

Aroa Biosurgery's Cost of Goods Sold for the six months ended in Mar. 2024 was A$4.55 Mil. Its Revenue for the six months ended in Mar. 2024 was A$34.38 Mil.

Aroa Biosurgery's COGS to Revenue for the six months ended in Mar. 2024 was 0.13.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Aroa Biosurgery's Gross Margin % for the six months ended in Mar. 2024 was 86.75%.

Aroa Biosurgery COGS-to-Revenue Historical Data

The historical data trend for Aroa Biosurgery's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery COGS-to-Revenue Chart

Aroa Biosurgery Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

COGS-to-Revenue

0.31

0.24

0.16

0.15

Aroa Biosurgery Semi-Annual Data
	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial			0.23	0.16	0.15	0.16	0.13

Aroa Biosurgery COGS-to-Revenue Calculation

Aroa Biosurgery's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	9.258	/	63.357
	=	0.15

Aroa Biosurgery's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	4.554	/	34.382
	=	0.13

Aroa Biosurgery (ASX:ARX) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Aroa Biosurgery's Gross Margin % for the six months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	4.554 / 34.382
	=	86.75 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Aroa Biosurgery COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Aroa Biosurgery's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Aroa Biosurgery (ASX:ARX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022

Website

https://www.aroabio.com

Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines